Breast cancer survivors who were active or moderately active had significantly reduced risk for death
THURSDAY, Nov. 17, 2022 (HealthDay News) — Even moderate physical activity is associated with a reduced risk for mortality for breast cancer survivors, according to a study published online Nov. 17 in JAMA Network Open.
Lie Hong Chen, Dr.P.H., from Kaiser Permanente Southern California in Pasadena, and colleagues conducted a cohort study of 315 postmenopausal breast cancer survivors who received their initial diagnosis at least two years earlier. Participants were initially diagnosed with early-stage breast cancer between 1996 and 2012. Using two validated questionnaires, participants were queried about leisure-time physical activity and fatigue.
The researchers found that 45 participants (14.3 percent) died due to any cause during a median follow-up of 8.7 years after baseline, including five who died due to breast cancer. The mortality rates were 12.9, 13.4, and 32.9 per 1,000 person-years for active, moderately active, and insufficiently active participants, respectively. Those who were active or moderately active had a significantly reduced risk for death compared with insufficiently active participants in a multivariable analysis (hazard ratio, 0.42 and 0.40, respectively).
“Our findings further suggest that survivorship care plans should consider incorporating physical activity because even moderate activity may be vital for extending survival as well as health-related quality of life,” the authors write. “Our findings have implications for patient counseling on the benefits of exercise with regard to cancer outcomes, and this protection persists even after considering cancer treatments in the analysis.”
Strength Training May Cut GDM Risk in Pregnant Women With Overweight, Obesity
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer
Stair Climbing Associated With Reduction in Cardiovascular, All-Cause Mortality
AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer
Estrogen Hormone Treatment May Be Beneficial for Brain Fog Symptoms in Menopausal Women
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease